Lincomycin Injectable, USP - Share Your Lincomycin Injectable, USP Experience with Community:
blog comments powered by DisqusANADA Number: 200-351 | |
| Proprietary Name |
Lincomycin Injectable, USP |
|---|---|
| Sponsor |
Teva Animal Health, Inc. |
| Sponsor Address |
3915 South 48th Street Ter. St. Joseph, MO 64506 USA |
| Ingredients |
Lincomycin |
| Species |
Swine, no use class stated or implied |
| Routes of Administration |
Intramuscular |
| Dose Form |
Liquid (solution) |
| Drug Form |
Liquid (solution) |
| Dispensing Status |
OTC |
| Withdrawal Time |
Swine: 48 hours before slaughter |
|
Dosage Amount, Indications & Limitations |
522.1260 Lincomycin injection. Specifications: Each milliliter of sterile aqueous solution contains lincomycin hydrochloride equivalent to 100 milligrams of lincomycin. Conditions of use: It is used for animals as follows: Swine Amount: 5 milligrams per pound of body weight per day. Administer intramuscularly as a single daily dose for 3 to 7 days. Indications: Treatment of infectious arthritis and mycoplasma pneumonia. Limitations: As lincomycin hydrochloride monohydrate. Do not treat within 48 hours of slaughter. |
| Tolerances |
A tolerance for residues of lincomycin in chickens is not required. Tolerances for lincomycin in swine of 0.6 part per million in liver and 0.1 part per million in muscle are established. |